These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 20667790)
1. Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Ahmed N; Wahlgren N; Grond M; Hennerici M; Lees KR; Mikulik R; Parsons M; Roine RO; Toni D; Ringleb P; Lancet Neurol; 2010 Sep; 9(9):866-74. PubMed ID: 20667790 [TBL] [Abstract][Full Text] [Related]
2. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Wahlgren N; Ahmed N; Dávalos A; Hacke W; Millán M; Muir K; Roine RO; Toni D; Lees KR; Lancet; 2008 Oct; 372(9646):1303-9. PubMed ID: 18790527 [TBL] [Abstract][Full Text] [Related]
3. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study. Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D; JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267 [TBL] [Abstract][Full Text] [Related]
4. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR. Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N; Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853 [TBL] [Abstract][Full Text] [Related]
5. Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register. Lees KR; Ford GA; Muir KW; Ahmed N; Dyker AG; Atula S; Kalra L; Warburton EA; Baron JC; Jenkinson DF; Wahlgren NG; Walters MR; QJM; 2008 Nov; 101(11):863-9. PubMed ID: 18694900 [TBL] [Abstract][Full Text] [Related]
6. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Bluhmki E; Chamorro A; Dávalos A; Machnig T; Sauce C; Wahlgren N; Wardlaw J; Hacke W Lancet Neurol; 2009 Dec; 8(12):1095-102. PubMed ID: 19850525 [TBL] [Abstract][Full Text] [Related]
7. The SITS-MOST registry. Toni D; Lorenzano S; Puca E; Prencipe M Neurol Sci; 2006 Jun; 27 Suppl 3():S260-2. PubMed ID: 16752063 [TBL] [Abstract][Full Text] [Related]
8. Thrombolysis for acute ischaemic stroke with alteplase in an Asian population: results of the multicenter, multinational Safe Implementation of Thrombolysis in Stroke-Non-European Union World (SITS-NEW). Rha JH; Shrivastava VP; Wang Y; Lee KE; Ahmed N; Bluhmki E; Hermansson K; Wahlgren N; Int J Stroke; 2014 Oct; 9 Suppl A100():93-101. PubMed ID: 22988894 [TBL] [Abstract][Full Text] [Related]
9. Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry. Kobayashi A; Czlonkowska A; Ahmed N; Romanowicz S; Glonek M; Nyka WM; Opala G; Wahlgren N; Acta Neurol Scand; 2010 Oct; 122(4):229-36. PubMed ID: 19919643 [TBL] [Abstract][Full Text] [Related]
10. The Belgian experience with intravenous thrombolysis for acute ischemic stroke. Vanacker P; Thijs V; Peeters A; Bruneel B; Laloux P; Druwé P; De Deyn P; Ahmed N; Wahlgren N; Vanhooren G; Acta Neurol Belg; 2010 Jun; 110(2):157-62. PubMed ID: 20873445 [TBL] [Abstract][Full Text] [Related]
11. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST. Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA; Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855 [TBL] [Abstract][Full Text] [Related]
12. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study. Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482 [TBL] [Abstract][Full Text] [Related]
13. [Thrombolytic therapy for acute ischemic stroke. Experience of SITS (Safe Implementation of Thrombolysis in Stroke) register]. Rodríguez-Yáñez M; Alvarez-Sabín J; Dávalos A; Díez-Tejedor E; Castillo J Neurologia; 2009 Jun; 24(5):288-91. PubMed ID: 19642029 [TBL] [Abstract][Full Text] [Related]
14. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry. Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276 [TBL] [Abstract][Full Text] [Related]
15. Role of tissue plasminogen activator in acute ischemic stroke. Hatcher MA; Starr JA Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027 [TBL] [Abstract][Full Text] [Related]
16. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset. Lorenzano S; Toni D; Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526 [TBL] [Abstract][Full Text] [Related]
17. Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies. Külkens S; Hacke W Expert Rev Neurother; 2007 Jul; 7(7):783-8. PubMed ID: 17610385 [TBL] [Abstract][Full Text] [Related]
18. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Wahlgren N; Ahmed N; Dávalos A; Ford GA; Grond M; Hacke W; Hennerici MG; Kaste M; Kuelkens S; Larrue V; Lees KR; Roine RO; Soinne L; Toni D; Vanhooren G; Lancet; 2007 Jan; 369(9558):275-82. PubMed ID: 17258667 [TBL] [Abstract][Full Text] [Related]
19. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Seet RC; Rabinstein AA Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870 [TBL] [Abstract][Full Text] [Related]
20. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry. Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]